Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Egile Nagusiak: Shinya Takasaki (Egilea), Hisanobu Adachi (Egilea), Yoshihide Kawasaki (Egilea), Masafumi Kikuchi (Egilea), Akihiro Ito (Egilea), Nariyasu Mano (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...